BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| rosmarinus officinalis {rosemary} - Staphylococcus intermedius group |
👶
Biological activities of Rosmarinus officinalis L. (rosemary) extract as analyzed in microorganisms and cells. Experimental biology and medicine (Maywood, N.J.) (Exp Biol Med (Maywood) ) Vol: 242 Issue 6 Pages: 625-634 Pub: 2017 Mar Epub: 2017 Jan 17 Authors de Oliveira JR , de Jesus D , Figueira LW , de Oliveira FE , Pacheco Soares C , Camargo SE , Jorge AO , de Oliveira LD , Html Article Publication |
| rosmarinus officinalis {rosemary} - Staphylococcus intermedius group |
👪
Antibacterial Potential of Essential Oils and Silver Nanoparticles against Multidrug-Resistant Staphylococcus pseudintermedius Isolates. Pathogens (Basel, Switzerland) (Pathogens ) Vol: 13 Issue 2 Pages: Pub: 2024 Feb 9 Epub: 2024 Feb 9 Authors Meroni G , Laterza G , Tsikopoulos A , Tsikopoulos K , Vitalini S , Scaglia B , Iriti M , Bonizzi L , Martino PA , Soggiu A , Html Article Publication |
| rosmarinus officinalis {rosemary} - Staphylococcus intermedius group |
👶
In-vitro antimicrobial activity and synergistic/antagonistic effect of interactions between antibiotics and some spice essential oils. Journal of environmental biology (J Environ Biol ) Vol: 32 Issue 1 Pages: 23-9 Pub: 2011 Jan Epub: Authors Toroglu S , |
| rosmarinus officinalis {rosemary} - Staphylococcus intermedius group |
👶
Antimicrobial and antiplasmid activities of essential oils. Fitoterapia (Fitoterapia ) Vol: 77 Issue 4 Pages: 279-85 Pub: 2006 Jun Epub: 2006 May 11 Authors Schelz Z , Molnar J , Hohmann J , Publication Publication |
| rosmarinus officinalis {rosemary} - Staphylococcus intermedius group |
👶
In vitro antimicrobial activity of essential oils from aromatic plants against selected foodborne pathogens. Journal of food protection (J Food Prot ) Vol: 67 Issue 6 Pages: 1252-6 Pub: 2004 Jun Epub: Authors Rota C , Carramiñana JJ , Burillo J , Herrera A , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
